No action on summons against Subhash Chandra for 3 weeks in fund diversion case: Sebi to HC

Sebi halts action on Chandra's summons after court challenge. Accusations of predetermined probe. Justices permit 3-week pause. Mustafa Doctor mentions key dates. Involves stock market regulator.

Mumbai: The Securities and Exchange Board of India () on Wednesday told the it would not take any further action on the summons issued by it to Chairman in an alleged .

Chandra had filed a petition earlier this month challenging the summons and had sought for it to be quashed. The businessman's counsel, Ravi Kadam, sought for the entire proceedings initiated by the Sebi to be quashed and argued that the watchdog was going ahead with the probe in a "predetermined" manner.

A division bench of Justices Girish Kulkarni and Firdosh Pooniwalla on Wednesday permitted the Sebi to file its affidavit in reply to Chandra's petition. The regulator's counsel, Mustafa Doctor, told the bench that for a period of three weeks from today (March 20), no further action under the summons shall be taken.

"We accept the statement," the bench said and posted the matter for further hearing on April 10. In January, the regulator had issued multiple summonses to Chandra.

Source: Stocks-Markets-Economic Times

Publicații recente
Novo Nordisk shares fall after Monlunabant phase 2a trial results; Viking jumps
20.09.2024 - 18:00
RBC says this stock is a 'top mid-cap cybersecurity idea,' starts coverage at Buy
20.09.2024 - 18:00
Ryman Hospitality Properties director sells $96,588 in company stock
20.09.2024 - 18:00
Trump Media shares drop after lock-up expires
20.09.2024 - 18:00
ECB Bancorp CFO acquires $69.9k in company stock
20.09.2024 - 18:00
Earnings call: Alliance Entertainment announces mixed FY 2024 results
20.09.2024 - 18:00
Fed's relaxed bank-capital plan faces FDIC pushback, Bloomberg News reports
20.09.2024 - 18:00
Nike veteran Hill to replace Donahoe as CEO; shares jump  
20.09.2024 - 18:00
Novo Nordisk shares drop more than 4% on disappointing obesity pill data
20.09.2024 - 18:00
Johnson Controls EVP and CFO sells $13.7k in stock
20.09.2024 - 18:00
'Temu Threat Abating in 2Q24' - Barclays
20.09.2024 - 18:00
Here's why BTIG says they would be "patient buyers" after large Fed rate cut
20.09.2024 - 18:00
US FDA approves Zevra's treatment for rare genetic disease
20.09.2024 - 18:00
Premier Inc. CFO Craig McKasson sells $204,100 worth of shares
20.09.2024 - 18:00
Earnings call: iPower reports mixed results, optimistic about 2025
20.09.2024 - 18:00

© Analytic DC. All Rights Reserved.

new
Analiza pieței Analiza complexǎ a petrolului WTI
Bine ați venit în mesageria de suport!!
*
*

Solicitarea dvs. a fost trimisă cu succes!
Veți fi contactat în scurt timp.